ALAM JOHN J 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Jul 25, 2008
Insider Transaction Report
Form 4
ALAM JOHN J
SVP, Drug Eval. & Appr.
Transactions
- Award
Stock Options
2008-07-24+36,250→ 36,250 totalExercise: $32.16From: 2008-10-24Exp: 2018-07-23→ Common Stock (36,250 underlying)
Footnotes (1)
- [F1]Right to buy under 2006 Stock and Option Plan, vesting in 16 equal quarterly installments from 07/24/2008.